Medivir Aktiebolag (MVIR.ST)
Nasdaq Stockholm · Financial statements, TTM figures and earnings dates
Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| SEK | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Operating income | −SEK 127.3M | −SEK 91.4M | −SEK 87.4M | −SEK 62.1M | −SEK 42.9M |
| Net income | −SEK 123.3M | −SEK 89.3M | −SEK 88.8M | −SEK 63.1M | −SEK 42.6M |
| Diluted EPS | −SEK 1.08 | −SEK 1.48 | −SEK 1.59 | −SEK 1.20 | −SEK 1.75 |
| Cash flow | |||||
| Operating cash flow | −SEK 124.2M | −SEK 59.7M | −SEK 101.8M | −SEK 48.7M | −SEK 58.1M |
| Capital expenditure | SEK 0 | SEK 0 | SEK 382.0K | SEK 0 | SEK 2.7M |
| Free cash flow | −SEK 124.2M | −SEK 59.7M | −SEK 102.2M | −SEK 48.7M | −SEK 60.7M |
| Balance sheet | |||||
| Cash and equivalents | SEK 62.5M | SEK 169.5M | SEK 117.4M | SEK 221.2M | SEK 70.0M |
| Total assets | SEK 172.6M | SEK 287.9M | SEK 234.2M | SEK 335.8M | SEK 191.5M |
| Total liabilities | SEK 57.1M | SEK 70.0M | SEK 41.4M | SEK 54.7M | SEK 49.6M |
| Shareholders' equity | SEK 115.5M | SEK 217.9M | SEK 192.8M | SEK 281.1M | SEK 141.9M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full MVIR.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open MVIR.ST financials →